China National Accord Medicines Corporation Ltd. (SHE:000028)
China · Delayed Price · Currency is CNY 26.44
-0.05 (-0.19%)
At close: Feb 6, 2026
SHE:000028 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 534.07 | 642.49 | 1,599 | 1,487 | 1,336 | 1,402 |
Depreciation & Amortization | 1,513 | 1,513 | 1,426 | 1,307 | 1,242 | 1,035 |
Other Amortization | 230.52 | 230.52 | 163.56 | 180.31 | 188.65 | 158.89 |
Loss (Gain) From Sale of Assets | -11.87 | -11.87 | -45.31 | -6.26 | -2.7 | -5.57 |
Asset Writedown & Restructuring Costs | 971.84 | 971.84 | 0.63 | 55.64 | 236.84 | 0.08 |
Loss (Gain) From Sale of Investments | -356.87 | -356.87 | -309.08 | -28.87 | - | - |
Provision & Write-off of Bad Debts | 94.15 | 94.15 | 71.36 | 29.77 | 44.22 | 21.23 |
Other Operating Activities | -1,755 | -119.54 | 630.83 | 357.4 | 131.94 | 256.33 |
Change in Accounts Receivable | -965.33 | -965.33 | -3,992 | 1,227 | -2,121 | -2,990 |
Change in Inventory | 559.6 | 559.6 | -170.13 | -217.84 | -1,260 | -406.38 |
Change in Accounts Payable | 463.05 | 463.05 | 3,688 | -1,949 | 2,135 | 2,125 |
Change in Other Net Operating Assets | 305.42 | 305.42 | -79.9 | 193.22 | -203.6 | -81.3 |
Operating Cash Flow | 1,527 | 3,271 | 2,937 | 2,560 | 1,655 | 1,503 |
Operating Cash Flow Growth | -44.52% | 11.38% | 14.71% | 54.69% | 10.14% | -25.34% |
Capital Expenditures | -252.52 | -282.7 | -322.21 | -322.19 | -370.43 | -293.83 |
Sale of Property, Plant & Equipment | 1.71 | 1.2 | 37.88 | 4.94 | 1.02 | 8.57 |
Cash Acquisitions | -7.42 | -71.4 | - | -126.35 | -109.95 | -2,646 |
Divestitures | - | - | 3.23 | - | - | - |
Investment in Securities | 2.88 | 6.58 | -3.72 | 89.66 | -144.03 | -31.09 |
Other Investing Activities | 98.82 | 195.63 | 149.38 | 11.12 | 167.86 | 179.21 |
Investing Cash Flow | -156.53 | -150.69 | -135.43 | -342.82 | -455.53 | -2,783 |
Short-Term Debt Issued | - | 1,560 | 1,873 | - | 81.45 | 160.7 |
Long-Term Debt Issued | - | - | 4 | 1,520 | 932.68 | 857.52 |
Total Debt Issued | 2,070 | 1,560 | 1,877 | 1,520 | 1,014 | 1,018 |
Short-Term Debt Repaid | - | -1,575 | -2,363 | -72.45 | -65.7 | -362.3 |
Long-Term Debt Repaid | - | -1,224 | -1,272 | -2,629 | -2,100 | -1,700 |
Total Debt Repaid | -2,827 | -2,799 | -3,635 | -2,701 | -2,165 | -2,063 |
Net Debt Issued (Repaid) | -757.25 | -1,239 | -1,758 | -1,181 | -1,151 | -1,044 |
Issuance of Common Stock | - | - | 31.6 | - | - | - |
Common Dividends Paid | -395.83 | -603.77 | -559.07 | -574.19 | -610.54 | -549.91 |
Other Financing Activities | -5.79 | 11.29 | -121.87 | 247.65 | -109.86 | -146.1 |
Financing Cash Flow | -1,159 | -1,831 | -2,408 | -1,508 | -1,872 | -1,740 |
Foreign Exchange Rate Adjustments | -0.07 | -1.2 | -0.94 | -1.19 | 0.39 | -0.05 |
Net Cash Flow | 211.83 | 1,288 | 393.12 | 708.66 | -671.6 | -3,021 |
Free Cash Flow | 1,275 | 2,989 | 2,615 | 2,238 | 1,285 | 1,209 |
Free Cash Flow Growth | -48.00% | 14.30% | 16.83% | 74.22% | 6.27% | -31.34% |
Free Cash Flow Margin | 1.75% | 4.02% | 3.46% | 3.05% | 1.88% | 2.03% |
Free Cash Flow Per Share | 2.29 | 5.37 | 4.69 | 4.02 | 2.31 | 2.17 |
Cash Interest Paid | - | - | - | - | - | 20.14 |
Cash Income Tax Paid | 1,678 | 1,771 | 1,887 | 1,782 | 1,564 | 1,498 |
Levered Free Cash Flow | 2,387 | 1,966 | 877.02 | 2,410 | 135.8 | -16.63 |
Unlevered Free Cash Flow | 2,507 | 2,127 | 1,032 | 2,573 | 315.83 | 144.74 |
Change in Working Capital | 307.52 | 307.52 | -599.77 | -821.69 | -1,523 | -1,365 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.